feed,title,long_url,short_url
Benzinga,Dyne Therapeutics Highlights New Preclinical Data For Duchenne Muscular Dystrophy Program,https://benzinga.com/general/biotech/21/10/23194053/dyne-therapeutics-highlights-new-preclinical-data-for-duchenne-muscular-dystrophy-program,https://j.mp/3ioUllY
